—
Multi-Component Regenerative Research
Various authors
Research interest in component combinations spans tissue repair, vascular remodeling, and inflammation modulation.
Featured Blend
Lot CB26-04-004MFG 04/2026
About KLOW
KLOW is a multi-peptide blend combining GHK-Cu, BPC-157, TB-500 fragment, and KPV in a single 80 mg lyophilized formulation. The blend is supplied for comprehensive regenerative-research applications where multi-component intervention is part of the study design.
Component peptides are individually tested for identity and purity before blending; the final product is independently verified for aggregate purity and endotoxin content per batch.
Each component peptide is documented in its own monograph in the COA Library for reference.
Identity & Specifications
Sequence
GHK-Cu · BPC-157 · TB-500 · KPV
Length
4-component blend
Formula
Multi-component
Mol. weight
Aggregate
CAS
— (blend)
PubChem
— (blend)
Purity (HPLC)
≥ 98.4%
Endotoxin (LAL)
0.31 EU/mg
Reconstitution
Bacteriostatic water
Storage
−20°C, sealed
Certificate of Analysis · Lot CB26-04-004
| Parameter | Method | Spec | Result |
|---|---|---|---|
| Identity | ESI-MS | Conforms | Pass |
| Purity | HPLC-UV 220 nm | ≥ 98.0% | 98.4% |
| Endotoxin | LAL kinetic | < 0.5 EU/mg | 0.31 EU/mg |
| Bioburden | Microbial count | < 100 CFU/g | < 10 CFU/g |
| Water content | Karl Fischer | ≤ 6.0% | 4.10% |
| Appearance | Visual | White lyophilized cake | Conforms |
Selected References
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways. Biomed Res Int, 2015.
- Sikiric P, et al. Stable gastric pentadecapeptide BPC-157. Curr Pharm Des, 2014.
- Crockford D, et al. Thymosin beta-4: structure, function, and biological properties. Ann NY Acad Sci, 2010.
- Lipton JM, Catania A. α-MSH peptides for inflammation. Ann NY Acad Sci, 1998.
- Component certificates of analysis are issued individually and bundled with each KLOW lot.
Recent Research Highlights
—
GHK-Cu Component
Pickart et al.
See GHK-Cu monograph for component-specific literature.
—
BPC-157 Component
Sikiric et al.
See BPC-157 monograph for component-specific literature.
—
TB-500 / KPV Components
Goldstein, Lipton et al.
See respective monographs for component-specific literature.
⊕
3rd Party Tested
Independent lab
≥98%
HPLC Purity
+ ESI-MS
LAL
Endotoxin
LAL kinetic
§
Lot-traceable
In COA library
§ Research-Use Compliance
This compound is supplied by Crescent Bioresearch LLC for laboratory research and pre-clinical use only. It is not a drug, dietary supplement, food, or cosmetic, and has not been approved by the U.S. Food and Drug Administration for human or veterinary administration, diagnosis, treatment, or prevention of any condition.
The pharmacological, toxicological, and stability properties of this compound have not been fully studied. It must therefore be handled only by personnel trained in laboratory safety practices.
The purchaser bears sole responsibility for ensuring that all handling, storage, and intended use comply with applicable local, state, and federal regulations. Full terms are set out in the RUO Disclaimer and Terms of Service.
